Lymphocyte replicating ability in individuals exposed to arsenic via drinking water. 1994

M E Gonsebatt, and L Vega, and R Montero, and G Garcia-Vargas, and L M Del Razo, and A Albores, and M E Cebrian, and P Ostrosky-Wegman
Instituto de Investigaciones Biomédicas, UNAM, DF, Mexico.

A human monitoring study was carried out to explore the effect on lymphocyte proliferation of chronic exposure to arsenic (As) via drinking water. Blood and urine samples were taken from volunteers from a town where levels of As in the drinking water averaged 412 micrograms/l, and from a matched group of individuals, with similar socioeconomic status, that drank water with As average levels of 37.2 micrograms/l. Exposure was assessed by questionnaires and by determining the levels of As in urine and water samples. The evaluation of the peripheral blood lymphocyte proliferation was done at different culture times using labelling (LI), mitotic (MI) and replication indexes (RI) as endpoints. No significant differences were seen for either LI or MI, except for MI in 72 h cultures and in LI in males and females with skin lesions vs. those without lesions. Significant differences in RI were seen for exposed females but not for males. Correlations between LI and MI showed that progression from the initial S-to M-phase is altered in exposed individuals. Arsenic exposure as well as lead and mercury affect cellular immune response, making the endpoints of cell proliferation variables of interest in population monitoring study design, since they might provide information in health impairment due to exposure, which is important in risk assessment.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008940 Mitotic Index An expression of the number of mitoses found in a stated number of cells. Index, Mitotic,Indices, Mitotic,Mitotic Indices
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004781 Environmental Exposure The exposure to potentially harmful chemical, physical, or biological agents in the environment or to environmental factors that may include ionizing radiation, pathogenic organisms, or toxic chemicals. Exposure, Environmental,Environmental Exposures,Exposures, Environmental
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M E Gonsebatt, and L Vega, and R Montero, and G Garcia-Vargas, and L M Del Razo, and A Albores, and M E Cebrian, and P Ostrosky-Wegman
February 2012, Toxicology and applied pharmacology,
M E Gonsebatt, and L Vega, and R Montero, and G Garcia-Vargas, and L M Del Razo, and A Albores, and M E Cebrian, and P Ostrosky-Wegman
April 1994, Mutation research,
M E Gonsebatt, and L Vega, and R Montero, and G Garcia-Vargas, and L M Del Razo, and A Albores, and M E Cebrian, and P Ostrosky-Wegman
January 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
M E Gonsebatt, and L Vega, and R Montero, and G Garcia-Vargas, and L M Del Razo, and A Albores, and M E Cebrian, and P Ostrosky-Wegman
December 2008, Environmental health perspectives,
M E Gonsebatt, and L Vega, and R Montero, and G Garcia-Vargas, and L M Del Razo, and A Albores, and M E Cebrian, and P Ostrosky-Wegman
January 2001, Anticancer research,
M E Gonsebatt, and L Vega, and R Montero, and G Garcia-Vargas, and L M Del Razo, and A Albores, and M E Cebrian, and P Ostrosky-Wegman
January 2001, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals,
M E Gonsebatt, and L Vega, and R Montero, and G Garcia-Vargas, and L M Del Razo, and A Albores, and M E Cebrian, and P Ostrosky-Wegman
August 2006, Environmental health perspectives,
M E Gonsebatt, and L Vega, and R Montero, and G Garcia-Vargas, and L M Del Razo, and A Albores, and M E Cebrian, and P Ostrosky-Wegman
November 2001, Journal of toxicology and environmental health. Part A,
M E Gonsebatt, and L Vega, and R Montero, and G Garcia-Vargas, and L M Del Razo, and A Albores, and M E Cebrian, and P Ostrosky-Wegman
April 2003, International journal of cancer,
M E Gonsebatt, and L Vega, and R Montero, and G Garcia-Vargas, and L M Del Razo, and A Albores, and M E Cebrian, and P Ostrosky-Wegman
April 2002, Mutation research,
Copied contents to your clipboard!